Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Chunhong Li, Zhen Wang, Hui Lei & Dan Zhang. (2023) Recent progress in nanotechnology-based drug carriers for resveratrol delivery. Drug Delivery 30:1.
Read now
Read now
Manish Kumar, Abhishek Jha, Kanchan Bharti, Gourav Parmar & Brahmeshwar Mishra. (2022) Advances in Lipid-Based Pulmonary Nanomedicine for The Management of Inflammatory Lung Disorders. Nanomedicine 17:12, pages 913-934.
Read now
Read now
Articles from other publishers (19)
Manish Kumar, Abhishek Jha, Kanchan Bharti, Manjit Manjit, Pradnya Kumbhar, Vividha Dhapte-Pawar & Brahmeshwar Mishra. (2024) Lipid-coated nanocrystals of paclitaxel as dry powder for inhalation: Characterization, in-vitro performance, and pharmacokinetic assessment. Colloids and Surfaces B: Biointerfaces 237, pages 113865.
Crossref
Crossref
Hamza Boucetta, Lei Zhang, Alejandro Sosnik & Wei He. (2024) Pulmonary arterial hypertension nanotherapeutics: New pharmacological targets and drug delivery strategies. Journal of Controlled Release 365, pages 236-258.
Crossref
Crossref
Heba A. Fayyaz, Magda A. EL-Massik, Mohammed Bahey-El-Din, Amany Abdel-Bary, Ossama Y. Abdallah & Hoda M. Eltaher. (2024) Targeted DPPC/DMPG surface-modified voriconazole lipid nanoparticles control invasive pulmonary aspergillosis in immunocompromised population: in-vitro and in-vivo assessment. International Journal of Pharmaceutics 649, pages 123663.
Crossref
Crossref
Mojtaba Falahati, Anwarul Hasan, Hojjat Alizadeh Zeinabad, Vahid Serpooshan, J.H. von der Thüsen & Timo L.M. ten Hagen. (2023) Engineering of pulmonary surfactant corona on inhaled nanoparticles to operate in the lung system. Nano Today 52, pages 101998.
Crossref
Crossref
Andrea Gonsalves, Parand Sorkhdini, Jasmine Bazinet, Moez Ghumman, Dinesh Dhamecha, Yang Zhou & Jyothi U. Menon. (2023) Development and characterization of lung surfactant-coated polymer nanoparticles for pulmonary drug delivery. Biomaterials Advances 150, pages 213430.
Crossref
Crossref
Elaheh Mirhadi, Prashant Kesharwani, Thomas P. Johnston & Amirhossein Sahebkar. (2023) Nanomedicine-mediated therapeutic approaches for pulmonary arterial hypertension. Drug Discovery Today 28:6, pages 103599.
Crossref
Crossref
Shuya Wang, Qiaohui Chen, Tianjiao Zhao, Kelong Ai & Changping Hu. (2023) Nanomedicine-based treatment: An emerging therapeutical strategy for pulmonary hypertension. Nano Research 16:5, pages 7007-7029.
Crossref
Crossref
Xiuli Yang, Yang Yang, Ke Liu & Chuantao Zhang. (2023) Traditional Chinese medicine monomers: Targeting pulmonary artery smooth muscle cells proliferation to treat pulmonary hypertension. Heliyon 9:4, pages e14916.
Crossref
Crossref
Eknath Kole, Krishna Jadhav, Nitin Shirsath, Prashik Dudhe, Rahul K. Verma, Aniruddha Chatterjee & Jitendra Naik. (2023) Nanotherapeutics for pulmonary drug delivery: An emerging approach to overcome respiratory diseases. Journal of Drug Delivery Science and Technology 81, pages 104261.
Crossref
Crossref
Debora Santonocito & Carmelo Puglia. (2023) Nanotechnological Systems and Lung: A Perfect Combination for Lung Pharmaceutical Applications. Current Medicinal Chemistry 30:6, pages 725-743.
Crossref
Crossref
Kehui Zhu, Yingcan Xu, Rui Zhong, Wanjing Li, Hong Wang, Yee Shan Wong, Subramanian Venkatraman, Jiaxin Liu & Ye Cao. (2023) Hybrid liposome–erythrocyte drug delivery system for tumor therapy with enhanced targeting and blood circulation. Regenerative Biomaterials 10.
Crossref
Crossref
Shushu Xue, Junrong Jiao, Si Miao, Lijun Wang, Yang Liu, Qingjie Zhang, Qiyue Wang, Yu Xi & Yuanyuan Zhang. (2022) Lipid‐coated bismuth nanoflower as the thermos‐radio sensiti for therapy of lung metastatic breast cancer: Preparation, optimisation, and characterisation. IET Nanobiotechnology 16:9, pages 305-315.
Crossref
Crossref
Manisha Sandupama Abesekara & Ying Chau. (2022) Recent advances in surface modification of micro- and nano-scale biomaterials with biological membranes and biomolecules. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Crossref
Ellenmae W. X. Leong & Ruowen Ge. (2022) Lipid Nanoparticles as Delivery Vehicles for Inhaled Therapeutics. Biomedicines 10:9, pages 2179.
Crossref
Crossref
Xu Huang, Yang Zhang, Weiwei Zhang, Cheng Qin, Yan Zhu, Yan Fang, Yabin Wang, Chengchun Tang & Feng Cao. (2022)
Osteopontin-Targeted and PPARδ-Agonist-Loaded Nanoparticles Efficiently Reduce Atherosclerosis in Apolipoprotein E
–/–
Mice
. ACS Omega 7:33, pages 28767-28778.
Crossref
Crossref
Wenhao Wang, Zhengwei Huang, Ying Huang, Xuejuan Zhang, Jiayuan Huang, Yingtong Cui, Xiao Yue, Cheng Ma, Fangqin Fu, Wenhua Wang, Chuanbin Wu & Xin Pan. (2022) Pulmonary delivery nanomedicines towards circumventing physiological barriers: Strategies and characterization approaches. Advanced Drug Delivery Reviews 185, pages 114309.
Crossref
Crossref
Hari Prasad Devkota, Anjana Adhikari-Devkota, Keshav Raj Paudel, Nisha Panth, Gaurav Gupta, Dinesh Kumar Chellappan, Philip M. Hansbro & Kamal Dua. 2022. Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases. Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases
95
106
.
Konrad de Vries, Morné Strydom & Vanessa Steenkamp. (2021) A Brief Updated Review of Advances to Enhance Resveratrol’s Bioavailability. Molecules 26:14, pages 4367.
Crossref
Crossref
Himanshu Gandhi, Shikha Mahant, Amit Bansal & Deepak N. Kapoor. 2021. Targeting Cellular Signalling Pathways in Lung Diseases. Targeting Cellular Signalling Pathways in Lung Diseases
717
740
.